Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | ACE | P12821 | 6/20 | 0.40 |
| ▸ | PEPD | P12955 | 3/20 | 0.40 |
| ▸ | REN | P00797 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | F2 | P00734 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | LTA4H | P09960 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | HRH1 | P35367 | 1/20 | 0.40 |
| ▸ | THPO | P40225 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.40 |
| ▸ | XPNPEP1 | Q9NQW7 | 1/20 | 0.39 |
| ▸ | FKBP1A | P62942 | 3/20 | 0.39 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17955686 | 0.85 | HSD17B10 (0.44) | HSD17B10ACEPEPDRENKDM4E | |
| SCHEMBL7323258 | 0.83 | DPP4 (0.50) | HSD17B10ACEPEPDRENKDM4E | |
| SCHEMBL10768669 | 0.83 | HSD17B10 (0.42) | HSD17B10ACEPEPDRENKDM4E | |
| SCHEMBL7270677 | 0.83 | HSD17B10 (0.42) | HSD17B10ACEPEPDRENKDM4E | |
| SCHEMBL5435528 | 0.82 | DPP4 (0.46) | HSD17B10ACEPEPDRENXPNPEP1 | |
| SCHEMBL7281828 | 0.81 | HSD17B10 (0.40) | HSD17B10ACEPEPDRENKDM4E | |
| SCHEMBL7206198 | 0.81 | DPP4 (0.52) | HSD17B10ACEPEPDRENKDM4E | |
| Oxalic Acid SCHEMBL10872013 | 0.81 | DPP4 (0.48) | HSD17B10ACEPEPDRENKDM4E | |
| SCHEMBL15223614 | 0.81 | ACE (0.49) | HSD17B10ACEPEPDRENKDM4E | |
| SCHEMBL10556672 | 0.80 | ACE (0.66) | HSD17B10ACEPEPDRENKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10865183-B2 | Compounds, reagents, and uses thereof | METABOLON, INC. (US) | 2020-12-15 | — | — | US | disclosed |
| US-20190152907-A1 | COMPOUNDS, REAGENTS, AND USES THEREOF | METABOLON, INC. | 2019-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10865183-B2 | Compounds, reagents, and uses thereof | REN, ATP6V1B1, PKD1 | HSD17B10 625/4885ACE 316/4885PEPD 301/4885 |
| US-20190152907-A1 | COMPOUNDS, REAGENTS, AND USES THEREOF | REN, ATP6V1B1, PKD1 | HSD17B10 625/4885ACE 316/4885PEPD 301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.